Drug
Bh4
Bh4: highest development phase Post-Market, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BH4 NCT04227080 | Post-Market | Pku Phenylketonuria |
Latest
No recent events.
Follow Bh4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.